BCYC Bicycle Therapeutics plc

NASDAQ
$3.77

Bicycle Therapeutics plc (BCYC) is expected to report earnings on January 28, 2027, before the market open. The consensus earnings estimate is a loss of $0.36 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -3.8% since its last earnings release on October 29, 2026.

Bicycle Therapeutics plc Beat Consensus Estimates
Thursday, October 29, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 28
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.36)
Rev est $13.41M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.66

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Bicycle Therapeutics plc

Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge, United Kingdom.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.